Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
J Oral Pathol Med ; 43(7): 545-53, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24484176

ABSTRACT

BACKGROUND: Calcifying cyst odontogenic tumour (CCOT) is a rare benign cystic neoplasm of odontogenic origin. MMPs are responsible for extracellular matrix remodelling and, together their inhibitors and inducer, determinate the level of its turnover in pathological processes, leading to an auspicious microenvironment for tumour development. Thus, our goal was to evaluate matrix metalloproteinases (MMPs-2, -7, -9 and -14), their inhibitors (TIMPs-2, -3, -4 and RECK) and its inductor (EMMPRIN) expression in CCOT. MATERIALS AND METHODS: We used 18 cases of CCOT submitted to immunolocalization of the target proteins and analysed in both neoplastic odontogenic epithelial and stromal compartments. RESULTS: All molecules evaluated were expressed in both compartments in CCOT. In epithelial layer, immunostaining for MMPs, TIMPs, RECK and EMMPRIN was found in basal, suprabasal spindle and stellate cells surrounding ghost cells and ghost cells themselves, except for MMP-9 and TIMP-2 which were only expressed by ghost cells. In stromal compartment, extracellular matrix, mesenchymal (MC) and endothelial cells (EC) were positive for MMP-2, -7, TIMP-3 and -4, while MMP-9, TIMP-2 and RECK were positive only in MC and MMP-14 only in EC. Statistical significance difference was found between both compartments for MMP-9 (P < 0.001), RECK (P = 0.004) and EMMPRIN (P < 0.001), being more expressed in epithelium than in stroma. Positive correlation between both stromal EMMPRIN and RECK expression was found (R = 0.661, P = 0.003). CONCLUSIONS: We concluded that these proteins/enzymes are differentially expressed in both epithelium and stroma of CCOT, suggesting an imbalance between MMPs and their inducer/inhibitors may contribute on the tumour behaviour.


Subject(s)
Basigin/analysis , GPI-Linked Proteins/analysis , Matrix Metalloproteinases/analysis , Odontogenic Tumors/chemistry , Tissue Inhibitor of Metalloproteinases/analysis , Adolescent , Adult , Endothelial Cells/chemistry , Endothelial Cells/enzymology , Epithelium/chemistry , Epithelium/enzymology , Extracellular Matrix/chemistry , Extracellular Matrix/enzymology , Female , Humans , Male , Matrix Metalloproteinase 14/analysis , Matrix Metalloproteinase 2/analysis , Matrix Metalloproteinase 7/analysis , Matrix Metalloproteinase 9/analysis , Mesoderm/chemistry , Mesoderm/enzymology , Middle Aged , Neoplasm Proteins/analysis , Odontogenic Tumors/enzymology , Tissue Inhibitor of Metalloproteinase-2/analysis , Tissue Inhibitor of Metalloproteinase-3/analysis , Tumor Microenvironment , Young Adult , Tissue Inhibitor of Metalloproteinase-4
2.
Pathol Res Pract ; 209(11): 705-9, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24011615

ABSTRACT

The expression of metalloproteinases and their inhibitors has been related to different invasive and metastatic potentials in cancer. This study aims to investigate the immunohistochemical expression of TIMP-3 and MMP-9 in samples of basal cell carcinoma (BCC), squamous cell carcinoma of the skin (SCC), and actinic keratosis (AK). Immunohistochemistry was performed to evaluate the expression of TIMP-3 and MMP-9 in samples of BCC (n=22), SCC (n=10), and AK (n=15). Ten fields of both tumor parenchyma and tumor stroma were photographed and counted in image software. The ratio of positive cells to total cells was used to quantify the staining. A higher expression of MMP-9 was found in tumor stroma of SCC compared to BCC and AK. No significant differences in TIMP-3 expression were observed among the groups. Considering the well-described differences between these neoplasms, these results provide additional evidence of the role of MMP-9 in tumor invasiveness of keratinocyte-derived tumors.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Basal Cell/enzymology , Carcinoma, Squamous Cell/enzymology , Immunohistochemistry , Keratosis, Actinic/enzymology , Matrix Metalloproteinase 9/analysis , Skin Neoplasms/enzymology , Tissue Inhibitor of Metalloproteinase-3/analysis , Adult , Aged , Carcinoma, Basal Cell/pathology , Carcinoma, Squamous Cell/pathology , Female , Humans , Keratosis, Actinic/pathology , Male , Middle Aged , Neoplasm Invasiveness , Skin Neoplasms/pathology
3.
Reprod Toxicol ; 32(4): 449-62, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21963884

ABSTRACT

Maternal diabetes increases the risks for embryo malformations. Matrix metalloproteinase-2 (MMP-2) and MMP-9 are two relevant MMPs for embryo development. Here, we addressed whether changes in these MMPs and in tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) and TIMP-2 are altered in embryos and decidua from type 1 diabetic rats during early organogenesis. Our results demonstrate MMP-2 and MMP-9 overactivities and overexpression, together with increases in lipid peroxidation and nitric oxide production in embryos and decidua from diabetic animals. There is a concomitant increase in the inhibitory activity of TIMP-1 and TIMP-2 in embryos and decidua, and an increase in protein expression of embryonic TIMP-1 and TIMP-2. In situ zymography demonstrated MMPs overactivities despite increased TIMPs in embryos and decidua in maternal diabetes during early organogenesis. This study reveals that maternal diabetes leads to profound alterations in MMPs/TIMPs balance during embryo organogenesis, the gestational period during which most malformations are induced.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Embryo, Mammalian/metabolism , Matrix Metalloproteinases/metabolism , Organogenesis , Pregnancy in Diabetics/metabolism , Tissue Inhibitor of Metalloproteinases/metabolism , Animals , Decidua/chemistry , Decidua/enzymology , Decidua/metabolism , Embryo, Mammalian/chemistry , Embryo, Mammalian/enzymology , Female , Lipid Peroxidation , Matrix Metalloproteinase 2/analysis , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/analysis , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinases/analysis , Nitric Oxide/biosynthesis , Pregnancy , Rats , Rats, Wistar , Tissue Inhibitor of Metalloproteinase-1/analysis , Tissue Inhibitor of Metalloproteinase-1/metabolism , Tissue Inhibitor of Metalloproteinase-2/analysis , Tissue Inhibitor of Metalloproteinase-2/metabolism , Tissue Inhibitor of Metalloproteinase-3/analysis , Tissue Inhibitor of Metalloproteinase-3/metabolism , Tissue Inhibitor of Metalloproteinases/analysis
4.
J Periodontal Res ; 44(4): 443-51, 2009 Aug.
Article in English | MEDLINE | ID: mdl-18973535

ABSTRACT

BACKGROUND AND OBJECTIVE: Inflammatory immune reactions that occur in response to periodontopathogens are thought to protect the host against infection, but may trigger periodontal destruction. However, the molecular and genetic mechanisms underlying host susceptibility to periodontal infection and to periodontitis development have still not been established in detail. MATERIAL AND METHODS: In this study, we examined the mechanisms that modulate the outcome of Aggregatibacter (Actinobacillus) actinomycetemcomitans-induced periodontal disease in mice mouse strains selected for maximal (AIRmax) or minimal (AIRmin) inflammatory reactions. RESULTS: Our results showed that AIRmax mice developed a more severe periodontitis than AIRmin mice in response to A. actinomycetemcomitans infection, and this periodontitis was characterized by increased alveolar bone loss and inflammatory cell migration to periodontal tissues. In addition, enzyme-linked immunosorbent assays demonstrated that the levels of the cytokines interleukin-1beta, tumor necrosis factor-alpha and interleukin-17 were higher in AIRmax mice, as were the levels of matrix metalloproteinase (MMP)-2, MMP-13 and receptor activator of nuclear factor-kappaB ligand (RANKL) mRNA levels. However, the more intense inflammatory immune reaction raised by the AIRmax strain, in spite of the higher levels of antimicrobial mediators myeloperoxidase and inducible nitric oxide synthase, did not enhance the protective immunity to A. actinomycetemcomitans infection, because both AIRmax and AIRmin strains presented similar bacterial loads in periodontal tissues. In addition, the AIRmax strain presented a trend towards higher levels of serum C-reactive protein during the course of disease. CONCLUSION: Our results demonstrate that the intensity of the inflammatory immune reaction is associated with the severity of experimental periodontitis, but not with the control of A. actinomycetemcomitans periodontal infection, suggesting that the occurrence of hyperinflammatory genotypes may not be an evolutionary advantage in the complex host-pathogen interaction observed in periodontal diseases.


Subject(s)
Actinobacillus Infections/immunology , Aggregatibacter actinomycetemcomitans/immunology , Alveolar Bone Loss/immunology , Periodontitis/immunology , Alveolar Bone Loss/microbiology , Animals , C-Reactive Protein/analysis , Cell Movement/physiology , Colony Count, Microbial , Disease Susceptibility/immunology , Host-Pathogen Interactions , Interleukin-17/analysis , Interleukin-1beta/analysis , Leukocyte Count , Leukocytes/immunology , Male , Matrix Metalloproteinase 13/analysis , Matrix Metalloproteinase 2/analysis , Mice , Nitric Oxide Synthase Type II/analysis , Osteoprotegerin/analysis , Periodontitis/blood , Periodontitis/microbiology , Peroxidase/analysis , RANK Ligand/analysis , Tissue Inhibitor of Metalloproteinase-1/analysis , Tissue Inhibitor of Metalloproteinase-3/analysis , Tumor Necrosis Factor-alpha/analysis
SELECTION OF CITATIONS
SEARCH DETAIL